Close Menu

NEW YORK (GenomeWeb) – Hologic reported after the close of the market on Wednesday that its fourth quarter revenues rose 3 percent, driven by strong growth in sales within its gynecology surgical and molecular diagnostics businesses.

For the three months ended September 30, the firm reported revenues of $726.8 million up from $702.8 million a year ago, and beating the average consensus Wall Street estimate of $721.7 million. On a constant-currency basis, revenues increased 4 percent year over year.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.

Michael Caputo, the top Department of Health and Human Service spokesperson, is taking a leave of absence, CNN says.

CNBC reports that the CDC Director says a SARS-CoV-2 vaccine isn't likely to be generally available until the third quarter of 2021, timing President Donald Trump disputes.

In Nature this week: MassIVE.quant resource houses mass spectrometry-based proteomic data, influence of Viking genetics on European populations, and more.